The surgically resected specimen demonstrated both adenocarcinoma and neuroendocrine components; therefore, it was diagnosed as HER2-negative mixed adenoneuroendocrine carcinoma. Here, ERBB2 is linked to digestive system mixed adenoneuroendocrine carcinoma.